MAR 09, 2021 8:00 AM PST

A 'Plug-and-Play' CRISPR Therapy for Flu and COVID

WRITTEN BY: Tara Fernandez

Researchers have developed a CRISPR treatment that could potentially treat both viruses that cause COVID-19 and influenza. The therapeutic comes in the form of a very fine mist that the patient can inhale, similar to an asthma inhaler, making it easy for patients to take at home.

Devastating influenza pandemics have left their mark on history: The 1918 influenza A pandemic that claimed 50 million lives worldwide and made a comeback in 2009, for instance. Emerging viruses such as COVID-19 also pose a very real threat to global health. As a result, organizations such as Defense Advanced Research Projects Agency's (DARPA) have been taking steps to create safe, effective medical countermeasures against viral threats that can be adapted and delivered to the masses rapidly. 

As part of the DARPA’s PReemptive Expression of Protective Alleles and Response Elements (PREPARE) program, researchers at the Georgia Institute of Technology and Emory University set out to use mRNA and CRISPR technology to tackle the problem of both influenza and COVID head-on. 

Their mRNA treatment codes for a protein called Cas13a, which acts as a pair of molecular scissors, chopping up the parts of the viral genetic code that are required for replication. This treatment is delivered via polymer nanoparticles and gets to work quickly, degrading viral RNA in the days following administration.

"In our drug, the only thing you have to change to go from one virus to another is the guide strand -- we only have to change one sequence of RNA. That's it," said lead researcher Philip Santangelo. 

"We went from flu to SARS-CoV-2, the virus that causes Covid-19. They're incredibly different viruses. And we were able to do that very, very rapidly by just changing a guide."

The team tested their treatment in mouse and hamster models of viral infection. When the animals received the therapy, Cas13a blocked the replication of SARS-CoV-2. The same approach could also be effective against 99% of flu strains that have decimated communities over the last century.

The best part is that scanning the genetic codes from emerging viruses and designing the appropriate guide strands to target them can be done in a matter of weeks.

"It's really quite plug-and-play," Santangelo said. "If you're talking about small tweaks versus large tweaks, it's a big bonus in terms of time. And in pandemics -- if we had had a vaccine in a month or two after the pandemic hit, think about what things would look like now. If we had a therapy a month after it hit, what would things look like now? It could make a huge difference, the impact on the economy, the impact on people."

 



Sources: Georgia Tech, Nature Biotechnology.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 27, 2020
Immunology
Thymus Transplantation?! It Could be Possible!
DEC 27, 2020
Thymus Transplantation?! It Could be Possible!
The thymus is an essential organ of the lymphatic system; it is responsible for developing mature T cells. T c ...
JAN 06, 2021
Immunology
What's Causing Prostate Cancer Patients to Doze Off?
JAN 06, 2021
What's Causing Prostate Cancer Patients to Doze Off?
For prostate cancer patients, androgen deprivation therapy or ADT is a standard treatment aimed at stalling the growth o ...
JAN 18, 2021
Immunology
Arthritis Drug Approved for Critically Ill COVID Patients
JAN 18, 2021
Arthritis Drug Approved for Critically Ill COVID Patients
Critically ill COVID patients in the U.K. may receive an arthritis drug after a study showed that treatment lowered mort ...
FEB 02, 2021
Immunology
Tumors Under Seige by Cancer-Killing Salmonella
FEB 02, 2021
Tumors Under Seige by Cancer-Killing Salmonella
Salmonella is a genus of rod-shaped bacteria, often given a bad rap thanks to its association with food poisoning. But c ...
FEB 01, 2021
Microbiology
A Potential Leptospirosis Vaccine is Created
FEB 01, 2021
A Potential Leptospirosis Vaccine is Created
Spirochetes are a type of free-living, spiral-shaped bacteria, some of which are harmless and others that can cause dise ...
MAY 11, 2021
Genetics & Genomics
Gene Therapy Trial for Severe Immune Disorder is Successful
MAY 11, 2021
Gene Therapy Trial for Severe Immune Disorder is Successful
Severe combined immunodeficiency (SCID), which virtually eliminates a patient's immune system, and severely affects thei ...
Loading Comments...